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Research Report 
ABSTRACT  Caspofungin was the first member of a new class of antifungals 
called echinocandins to be approved by a drug regulatory authority. Like the 
other echinocandins, caspofungin blocks the synthesis of β(1,3)-D-glucan of 
the fungal cell wall by inhibiting the enzyme, β(1,3)-D-glucan synthase. Loss of 
β(1,3)-D-glucan leads to osmotic instability and cell death. However, the pre-
cise mechanism of cell death associated with the cytotoxicity of caspofungin 
was unclear. We now provide evidence that Saccharomyces cerevisiae cells 
cultured in media containing caspofungin manifest the classical hallmarks of 
programmed cell death (PCD) in yeast, including the generation of reactive 
oxygen species (ROS), the fragmentation of mitochondria, and the production 
of DNA strand breaks. Our data also suggests that deleting AIF1 but not 
YCA1/MCA1 protects S. cerevisiae and Candida albicans from caspofungin-
induced cell death. This is not only the first time that AIF1 has been specifical-
ly tied to cell death in Candida but also the first time that caspofungin re-
sistance has been linked to the cell death machinery in yeast.  
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INTRODUCTION 
Defined as any cell death that results from the activation of 
a genetic program, programmed cell death (PCD) has been 
classified by the Nomenclature Committee on Cell Death 
(NCCD) into twelve different functional categories based 
on measurable biochemical features [1]. In recent years, 
numerous laboratories have shown that a wide range of 
antifungal drugs leads to PCD in yeast that is reminiscent of 
apoptosis in mammalian cells [2]. This cell death is accom-
panied by several distinctive phenotypical markers, includ-
ing the generation of reactive oxygen species (ROS), the 
fragmentation of mitochondria, and the dissipation of the 
mitochondrial membrane potential [3-5]. It also involves 
intrinsic pathways of cell death defined by several genes, 
including AIF1, BIR1, BXI1, NMA111, and YCA1, which have 
homologs in the metazoa [6-11]. 
Caspofungin was the first member of the class of anti-
fungals called the echinocandins to be approved by a drug 
regulatory authority [12, 13]. Like the other echinocandins, 
caspofungin blocks the synthesis of β(1,3)-D-glucan of the 
fungal cell wall by inhibiting the enzyme, β(1,3)-D-glucan 
synthase [14]. However, the precise mechanism of cell 
death associated with the cytotoxicity of caspofungin was 
unclear. 
In this report, we provide evidence that Saccharomyces 
cerevisiae cells cultured in media containing caspofungin 
manifest the classical hallmarks of PCD in yeast, including 
the generation of reactive oxygen species (ROS), the frag-
mentation of mitochondria, and the activation of caspase-
like activity. Moreover, our data also suggests that this cell 
death scenario requires the pro-apoptotic gene, AIF1, but 
not the metacaspase, YCA1, in both S. cerevisiae and Can-
dida albicans. Our findings reveal an additional dimension 
of caspofungin’s mechanism of action as a general anti-
fungal agent that points to a possible novel pathway to 
drug resistance.  
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FIGURE 1: Saccharomyces cerevisiae cells cultured in caspofungin manifest numerous phenotypic markers associated with yeast pro-
grammed cell death. Exponentially-growing wildtype cells from the W303-1A strain background were cultured in YPD containing 
0.02µg/ml caspofungin for three hours. The cells were stained with 2.5µM CellROX Green to detect ROS (A, E); with a FLICA kit to detect 
activated caspase activity (B, F); and with the mitochondrial vital dye, JC-1, to assess their mitochondrial membrane potential (D, H). To 
visualize the structure of their mitochondria, the cells were transformed with a p416 GPD-mtGFP plasmid constitutively expressing a mi-
tochondria-localized GFP marker and their mitochondria were visualized after they had been treated with caspofungin as described above 
(C, G). Representative images are shown (A-D). Statistical significance for the graphs (E-H) was determined with the unpaired Student’s t-
test (**: p<0.05; ***: p<0.005), and a minimum of 500 cells was counted for each assay. 
RESULTS AND DISCUSSION 
To determine if caspofungin triggers PCD in budding yeast, 
we cultured W303-1A cells in YPD containing 0.02µg/ml 
caspofungin for three hours, a drug concentration below 
the MIC of 0.04µg/ml for this strain (data not shown). With 
this protocol, propidium iodide staining (50µg/ml) revealed 
that just over half of the cells (58±10%; p<0.005) were via-
ble as compared to cells grown in the absence of drug 
(99±0.1%). The cells were also treated with 2.5µM CellROX 
Green (Molecular Probes, Inc.) and imaged with a Zeiss 
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FIGURE 2: Deletion of AIF1 but not YCA1/MCA1 protects Saccharomyces cerevisiae and Candida albicans cells from caspofungin-
induced programmed cell death. (A) A series of ten-fold dilutions of two cultures each of wildtype, ∆aif, and ∆yca1 W303-1A Saccharomy-
ces cells were plated on YPD plates and YPD plates with 0.015 µg/ml caspofungin for two days. (B) A series of ten-fold dilutions of two 
independent cultures each of wildtype, aif∆/aif∆ and mca1∆/mca1∆ RBY1132 Candida cells were plated on YPD plates and YPD plates with 
the indicated concentrations of caspofungin for two days. Representative images are shown. 
 
LSM700 confocal microscope. We discovered that including 
caspofungin in the culture media generates significantly 
more fluorescent cells (18±5%; p<0.05; Figure 1A, E) as 
compared to controls (0.1±0.2%) suggesting that the drug 
induces the production of ROS, a characteristic hallmark of 
apoptotic cell death in yeast [3, 15].  
Next, we used a FLICA apoptosis detection kit (Immu-
noChemistry Technologies, LLC) according to the manufac-
turer’s specifications to determine if the caspofungin 
treatment described above also induced caspase activity in 
W303-1A cells. Numerous studies have associated caspase 
activation with apoptotic cell death, not only in yeast, but 
also in mammalian cells [16-18]. We discovered that drug 
treatment leads to significantly more cells with activated 
caspase-like activity (40±11%; p<0.05; Figure 1B, F) as 
compared to no-drug controls (7.3±13%).  
Third, we imaged the same yeast cells, this time trans-
formed with the p416 GPD-mtGFP plasmid constitutively 
expressing a mitochondria-localized GFP marker to visual-
ize the structure of their mitochondria [19], after they had 
been treated with caspofungin as described above. Several 
reports have shown that apoptosis in Saccharomyces cere-
visiae is accompanied by the fragmentation of mitochon-
dria [4, 20]. Our experiments revealed that the majority of 
mitochondria of the caspofungin-treated cells had lost 
their tubular architecture after three hours (77±15%; 
p<0.005; Figure 1C, G). In contrast, only a few cells cultured 
in media without the drug (2.4±5.6%) displayed the punc-
tate mitochondrial-staining pattern associated with frag-
mented mitochondria.  
Fourth, to determine the functional state of the mito-
chondria in cells treated with caspofungin as described 
above, we incubated the cells with the mitochondrial vital 
dye, JC-1 (5mM; Molecular Probes, Inc.) for 15min at 30∘C 
to assess their mitochondrial membrane potential (∆ψm). 
In healthy cells with high ∆ψm, JC-1 forms aggregates that 
exhibit intense red fluorescence, while in apoptotic cells 
with low ∆ψm, the dye remains in the monomeric form, 
which has green fluorescence [21-23]. Our experiments 
revealed that caspofungin-treated W303-1A cells had sig-
nificantly more unhealthy cells with low ∆ψm (30±4%; 
p<0.05; Figure 1D, H) than untreated controls (0.3±0.2%).  
In toto, all of our data suggests that caspofungin induc-
es PCD in S. cerevisiae cells. Notably, while our studies 
were in progress, a paper was published that reported that 
caspofungin induces PCD in the yeast, Candida albicans, 
accompanied with phenotypic markers characteristic of 
apoptosis and necrosis, including some of the markers de-
scribed above [24]. We have repeated and confirmed these 
results suggesting that caspofungin kills with a similar 
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mechanism of action in both Saccharomyces cerevisiae and 
Candida albicans (data not shown). 
Finally, ROS-mediated PCD in yeast is often distin-
guished into two different types depending upon their 
mechanism of killing, either caspase-dependent or caspa-
se-independent yeast apoptosis [18, 25, 26]. Caspase-
dependent cell death can be bypassed, at least in part, by 
the deletion of the yeast metacaspase, YCA1/MCA1 [6, 27, 
29]. In contrast, caspase-independent cell death cannot be 
suppressed by a YCA1/MCA1 deletion [29]. Importantly, 
the yeast homolog of the mammalian apoptosis-inducing 
factor, called AIF1 in both Saccharomyces cerevisiae and  
Candida alibcans, has often been linked to caspase-
independent cell death [7, 25].  
While the recent paper showed that caspofungin in-
duces PCD in Candida, it did not determine the mechanism 
of killing for the drug [24]. Indeed, the authors proposed 
that future studies should determine if either the caspase-
dependent or the independent pathway is also involved in 
regulating yeast apoptosis upon exposure of caspofungin. 
To see if caspofungin induces either caspase-dependent or 
caspase-independent cell death, we spotted a series of 
ten-fold dilutions of two cultures each of wildtype, ∆aif1, 
and ∆yca1 W303-1A cells on YPD plates and YPD plates 
with caspofungin. After two days, we discovered that the 
viability of cells lacking the metacaspase was indistinguish-
able from that of wildtype cells (Figure 2A). This suggests 
that the caspase-like activity that we observed with our 
FLICA assay described above is associated with caspases 
and/or proteases other than Yca1p [18]. However, ∆aif1 
cells were relatively more resistant to caspofungin killing 
suggesting that this anti-fungal agent triggers AIF1-
dependent PCD in Saccharomyces cerevisiae (Figure 2A). 
We repeated these experiments with wildtype, aif1∆/aif1∆, 
and mca1∆/mca1∆ mutants of Candida albicans, generous-
ly provided by Richard Bennett (Brown University). MCA1 is 
the Candida albicans homolog of the Saccharomyces cere-
visiae metacaspase gene, YCA1 [16], while AIF1 
(orf19.3362) is the single homolog of the Saccharomyces 
AIF1 gene [7, 25]. The assay was repeated with two inde-
pendent isolates for each Candida null mutant to ensure 
that the observed phenotype is due to the knockout of the 
ORF and not to some spurious mutation. Once again, after 
two days incubation, we discovered that aif1∆/aif1∆ cells 
were more resistant to caspofungin than either wildtype or 
mca1∆/mca1∆ cells (Figure 2B).  
In conclusion, our study suggests that caspofungin 
leads to caspase-independent cell death requiring AIF1 in 
both Saccharomyces cerevisiae and Candida albicans. Of 
significance, though caspase-independent cell death has 
been observed in Candida before [29], this is the first time 
that AIF1 has been implicated in this process for this path-
ogenic yeast. In sum, our findings reveal an additional di-
mension of this echinocandin’s mechanism of action as an 
anti-fungal agent. They also point to a novel scenario for 
the acquisition of caspofungin resistance since this is the 
first time that drug resistance in Candida has been linked 
to a gene involved in cell death.  
 
MATERIALS AND METHODS 
Yeast Strains and Growth Conditions 
All experiments were done with isogenic Saccharomyces cere-
visiae strains in the W303-1A background (MATa ade2, his3, 
leu2, trp1, ura3, ssd1-d2). The ∆yca1 mutant (SKY2880) was 
previously described [30]. The ∆aif1 mutant was created by 
disrupting the ORF with the kanR marker using a PCR-based 
knock-out strategy [31] and verified both by PCR and by phe-
notypic analysis. Experiments with Candida albicans were 
done with wildtype, aif1∆/aif1∆, and mca1∆/mca1∆ mutants 
of Candida albicans, generously provided by Richard Bennett 
(Brown University). Mutants were created in the wildtype 
RBY1132 strain background (MTL a/a, leu2/leu2 his1/his1 
arg4/arg4) by disrupting the ORF with a disruption cassette 
generated by fusion PCR and verified as previously described 
[32]. For all the experiments described in this paper, cells were 
cultured using standard protocols [33]. Caspofungin (Cancidas) 
was generously provided by Merck (Rahway, NJ) and by Timo-
thy Flanigan (Rhode Island Hospital/Warren Alpert School of 
Medicine at Brown University). Unless noted otherwise, all 
other drugs and reagents were purchased from SIGMA-Aldrich. 
 
Caspofungin Activity Assay 
Wildtype budding yeast cells in the W303-1A background 
were cultured in YPD overnight. In the morning, they were 
reinoculated in fresh media and allowed to grow for several 
hours until they reached the exponential phase (OD600 0.2-0.4). 
They were then resuspended at the same cell density in fresh 
media or in fresh media containing 0.02µg/ml caspofungin for 
three hours, a drug concentration below the MIC of 0.04µg/ml 
for this strain (data not shown). Next, the cells were washed 
and resuspended in a solution of YPD and 50µg/ml propidium 
iodide. Propidium iodide is a membrane impermeable fluores-
cent molecule that is excluded from viable cells. Fluorescent 
cells were counted with either a Zeiss Axiophot Fluorescence 
Microscope or a Zeiss LSM 700 Laser Confocal Microscope 
fitted with Filter Cube 43 Cy3/Rhod/RFP (EX BP 545/25, BS FT 
565, EM BP 606/70). Measurements were repeated with at 
least three independent cell cultures.  
 
Apoptosis Assays 
Wildtype budding yeast cells in the W303-1A background 
were cultured in YPD overnight. In the morning, they were 
reinoculated in fresh media and allowed to grow for several 
hours until they reached the exponential phase (OD600 0.2-0.4). 
They were then resuspended at the same cell density in fresh 
media or in fresh media containing 0.02µg/ml caspofungin for 
three hours. To detect the presence of reactive oxygen species 
(ROS), they were stained with 2.5µM CellROX Green (Molecu-
lar Probes, Inc.) for 10min at room temperature. This cell-
permeable dye exhibits bright fluorescence upon oxidation by 
ROS, which was visualized with a Zeiss LSM700 confocal mi-
croscope fitted with Filter Cube 38 GFP (EX BP 470/40, BS FT 
495, EM BP 525/50). Next, to determine the presence of acti-
vated caspase-like activity, they were stained with a FLICA 
apoptosis detection kit (ImmunoChemistry Technologies, LLC) 
according to the manufacturer’s specifications, and imaged 
with a Zeiss LSM700 confocal microscope fitted with Filter 
Cube 38 GFP. Third, to determine the functional state of the 
mitochondria in cells treated with caspofungin as described 
above, they were incubated with the mitochondrial vital dye, 
JC-1 (5mM; Molecular Probes, Inc.) for 15min at 30∘C to assess 
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their mitochondrial membrane potential (∆ψm). In healthy 
cells with high ∆ψm, JC-1 forms aggregates that exhibit intense 
red fluorescence, while in apoptotic cells with low ∆ψm, the 
dye remains in the monomeric form, which has green fluores-
cence [21-23]. Both were imaged with the Zeiss LSM700 fitted 
either with Filter Cube 43 Cy3/Rhod/RFP or with Filter Cube 38 
GFP. Finally, to detect the fragmentation of mitochondria, the 
cells were transformed with a p416 GPD-mtGFP plasmid con-
stitutively expressing a mitochondria-localized GFP marker 
[19], treated with caspofungin as described above, and im-
aged with a Zeiss LSM 700 Laser Confocal Microscope fitted 
with Filter Cube 38 GFP. For all the apoptosis assays, the ex-
periment was repeated with at least three independent cul-
tures. Representative images are shown with consistent pa-
rameters applied to comparable panels in each figure. Statisti-
cal significance was determined with the unpaired Student’s t-
test, and a minimum of 500 cells was counted for each assay. 
 
Spot Assays 
Wildtype and mutant cells of the indicated genotypes were 
grown overnight in YPD at 30oC (Saccharomyces) or at 37oC 
(Candida) respectively. For each yeast strain, a series of 10-
fold dilutions was then prepared in water with cells in the 
exponential phase (OD600 0.2-0.4) over a range of concentra-
tions from 10-1 to 10-5 relative to the initial culture. Spots of 5 
µl from each dilution series were then plated on the indicated 
media and cultured at 30oC (Saccharomyces) or at 37oC (Can-
dida) for 2 days. Plates supplemented with caspofungin were 
poured and used on the same day. All spot assays were re-
peated at least three times and a representative experiment is 
shown. 
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